Ionis Pharmaceuticals Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $1.81B | $2.52B | $542.5M |
| Jun 2022 | $1.83B | $2.46B | $521.9M |
| Sep 2022 | $1.83B | $2.42B | $315.0M |
| Dec 2022 | $1.96B | $2.53B | $276.5M |
| Mar 2023 | $2.40B | $2.89B | $309.0M |
| Jun 2023 | $2.54B | $2.97B | $424.8M |
| Sep 2023 | $2.62B | $2.93B | $352.1M |
| Dec 2023 | $2.60B | $2.99B | $399.3M |
| Mar 2024 | $2.47B | $2.76B | $348.9M |
| Jun 2024 | $2.43B | $2.69B | $294.0M |
| Sep 2024 | $2.42B | $3.08B | $334.6M |
| Dec 2024 | $2.42B | $3.00B | $242.1M |
| Mar 2025 | $2.34B | $2.81B | $264.2M |
| Jun 2025 | $2.35B | $2.99B | $297.3M |
| Sep 2025 | $2.42B | $3.03B | $338.3M |
| Dec 2025 | $3.03B | $3.52B | $372.3M |
| Mar 2026 | $2.96B | $3.45B | $173.4M |
| Jun 2026 | $2.55B | $2.99B | $350.1M |